Fall 2010 | Contemporary Oncology®

Triple Receptor-Negative Breast Cancer: Current and Future Treatments

March 04, 2011

Breast cancer is the number one malignancy diagnosed in women in the United States. In 2009, it was estimated that more than 190,000 individuals would be diagnosed with breast cancer and approximately 40,000 would die from the disease.

Abiraterone Praised as a Significant Advance in Metastatic Prostate Cancer

March 04, 2011

Data presented at the recent 35th European Society for Medical Oncology Congress in Milan, Italy, showed a significant survival advantage for men with advanced metastatic castration resistant prostate cancer (CRPC) who received abiraterone acetate compared with placebo.